Preliminary experience of the use of a self-expanding nititol stent in refractory variceal bleeding: a real-world study.

Autor:	García García MD; Gastroenterology and Digestive Endoscopy Unit, Hospital Universitario Virgen Macarena, España., Valdés Delgado T; Gastroenterology and Digestive Endoscopy Unit, Hospital Universitario Virgen Macarena, España., Fernández Álvarez P; Gastroenterology and Digestive Endoscopy Unit, Hospital Universitario Virgen Macarena, España., Lara Romero C; Gastroenterology and Digestive Endoscopy Unit, Hospital Universitario Virgen del Rocío, España., Grande Santamaría L; Gastroenterology and Digestive Endoscopy Unit, Hospital Universitario Virgen Macarena, Spain., Núñez Sousa MC; Gastroenterology and Digestive Endoscopy Unit, Hospital Universitario Juan Ramón Jiménez, España., García de la Borbolla Serres J; Gastroenterology and Digestive Endoscopy Unit, Hospital Universitario Virgen de Valme, España., Rodríguez-Téllez M; Gastroenterology and Digestive Endoscopy Unit, Hospital Universitario Virgen Macarena, España.
Jazyk:	angličtina
Zdroj:	Revista espanola de enfermedades digestivas [Rev Esp Enferm Dig] 2024 Sep; Vol. 116 (9), pp. 516-517.
DOI:	10.17235/reed.2023.10035/2023
Abstrakt:	Background and Aims: The fully-covered self-expanding metal stent (SEMS) has a role in the management of refractory acute variceal haemorrhage. The aim of this study was to evaluate its effectiveness and complications in real-world practice. Patients and Methods: An observational, descriptive, multicenter study was carried out. Eight patients with clinically significant portal hypertension who underwent a SEMS were included. Results: SEMS placement controlled acute bleeding in 7 patients with technical success. Stents were removed after a median of 8 days. Rescue transjugular intrahepatic portosystemic shunt was performed around 48 hours after SEMS placement. Four patients survived after successful SEMS removal. The most common adverse event was stent loop in 2 patients. Conclusions: In our experience, SEMS was highly effective in controlling acute refractory variceal bleeding. Bleeding-related mortality rate was probably due to impossibility of TIPS implantation. Stent loop was a common limiting factor.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu